IRIS
SARACENI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 770
EU - Europa 353
AS - Asia 53
AF - Africa 1
Totale 1.177
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 769
IT - Italia 98
SE - Svezia 64
UA - Ucraina 47
IE - Irlanda 46
DE - Germania 26
DK - Danimarca 16
GB - Regno Unito 16
FR - Francia 15
SG - Singapore 15
TR - Turchia 15
BE - Belgio 9
IN - India 9
FI - Finlandia 8
KR - Corea 7
CN - Cina 6
PL - Polonia 4
CH - Svizzera 2
CA - Canada 1
JP - Giappone 1
NL - Olanda 1
NO - Norvegia 1
ZA - Sudafrica 1
Totale 1.177
Salva come PNG Salva come JPEG
Città #
Chandler 173
Ashburn 62
Des Moines 61
Fairfield 55
Jacksonville 51
Dublin 46
New York 36
Wilmington 31
Centro 26
Seattle 24
Lawrence 19
Princeton 19
Redmond 19
Boardman 18
Woodbridge 18
Cambridge 15
Houston 15
Ann Arbor 13
San Mateo 12
Turin 12
San Diego 11
Brussels 9
Washington 9
Milan 7
Beijing 6
Jesi 5
Civitanova Marche 4
Leawood 4
Marche 4
Mumbai 4
Palermo 4
Pune 4
Rome 3
Ancona 2
Cremona 2
Fano 2
London 2
Prescot 2
Zurich 2
Bologna 1
Chicago 1
Chiswick 1
Edinburgh 1
Florence 1
Helsinki 1
Hounslow 1
Johannesburg 1
Kagoya 1
Kilburn 1
Lequile 1
Montesilvano 1
Montreal 1
New Bedfont 1
New Delhi 1
Norwalk 1
Oslo 1
Paris 1
Philadelphia 1
Porto Recanati 1
Portsmouth 1
Sant'angelo In Vado 1
Southwark 1
Udine 1
Totale 835
Salva come PNG Salva come JPEG
Nome #
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 100
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 92
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 85
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 84
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 78
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 76
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 73
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 71
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 71
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 69
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 65
Mobilization policy in multiple myeloma: Minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean 63
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 59
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 59
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 40
Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT) 35
new monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia 33
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 32
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study 27
Secondary Acute Myeloid Leukemia: Pathogenesis and Treatment 8
Totale 1.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 1 4
2019/202068 4 1 9 0 12 1 11 2 12 1 5 10
2020/2021214 13 18 22 24 21 4 11 20 20 22 22 17
2021/2022202 7 17 11 9 4 9 25 21 7 16 35 41
2022/2023448 41 53 26 37 35 103 1 24 87 3 32 6
2023/2024175 30 8 14 21 26 68 3 5 0 0 0 0
Totale 1.220